There’s a new result that shows a boost in cancer research. Check out the latest reports, which have been just revealed below.
Experimental CRISPR technology
Accoridng to the latest reports, it seems that there is a groundbreaking treatment that has cleared a teenage girl’s incurable cancer.
Back in May 2022, 13-year-old Alyssa from Leicester became the first reported patient in the world to receive a new kind of CRISPR called base editing.
“The base-edited T-cells at Great Ormand Street Hospital for Children (GOSH), in collaboration with the UCL Great Ormond Street Institute of Child Health (UCL GOS ICH), treated Alyssa’s “incurable” T cell leukemia, leaving her with zero detectable cancer cells,” a press release reported .
Here’s what the child said in the press release:
“Once I do it, people will know what they need to do, one way or another, so doing this will help people – of course, I’m going to do it.”
Using new base-editing technology, the cells were edited, thereby allowing them to chase and kill the cancerous T-cells without attacking each other.
“This is quite remarkable, although it is still a preliminary result, which needs to be monitored and confirmed over the next few months.” This is what Dr. Robert Chiesa, Consultant in Bone Marrow Transplant and CAR T-cell therapy at GOSH stated.
“We’re on a strange cloud nine, to be honest – it’s amazing to be home,” said Kiona, Alyssa’s mum.
We suggest that you check out the original article in order to learn more details.
News about spreading cancer cells
A novel mechanism that permits cancer cells to migrate throughout the body has been discovered by a team of researchers from around the world. This finding offers a possible new target for the treatment of metastasis, which is accountable for ninety percent of all deaths caused by cancer.
A shift that happens when lymph drainage is restricted by a primary tumor is that the fluids around the cancer cells become thicker, which causes the cancer cells to migrate at a faster rate. These findings were reported in the journal Nature.
